ADAM10 and Dimebolin
Researchers:
Funding year(s):
2009
Funding to date:
$150,000
Understanding the hypothesized relationship between ADAM10, a newly identified Alzheimer’s-related gene and dimebolin, the key ingredient in the anti-Alzheimer’s drug Dimebon.
